Calavo Growers Reports Third Quarter Results with Revenue Growth
Calavo Growers, Inc. Financial Performance Overview
Calavo Growers, Inc. (NASDAQ: CVGW), renowned for its expertise in sourcing and distributing fresh avocados, tomatoes, papayas, and guacamole products, recently shared its financial outcomes for the third quarter and the nine-month period concluded on July 31, 2025. The performance highlights a blend of challenges paired with opportunities for the company.
Third Quarter Financial Highlights
During the third quarter, Calavo experienced total net sales reaching $178.8 million. This reflects a slight decrease of less than one percent when compared to the previous year's figures. A deeper analysis of the fresh and prepared segments reveals contrasting trends:
Sales Breakdown
- Total net sales decreased slightly from last year.
- Fresh segment sales fell to $155.9 million, indicating a 5% decline year-over-year.
- Conversely, the prepared segment saw impressive growth, with sales increasing to $22.9 million, marking a notable 40% rise from the previous year.
Moreover, gross profit for the quarter was reported at $18.2 million, presenting a 9% decline relative to the previous year. This decrease included unusual costs—approximately $4.2 million associated with an FDA detention hold on certain avocado imports. This temporary regulatory issue led to additional third-party inspection, handling costs, and inventory write-downs.
Detailed Segment Profits
- Fresh segment gross profit dwindled to $12.4 million, down 32% from last year.
- The prepared segment showcased an impressive gross profit of $5.8 million, reflecting a staggering 201% increase from the prior year, largely attributed to improved operational efficiencies.
Despite the challenges in the fresh segment, expenses related to selling, general, and administrative operations (SG&A) were reduced by 12%, totaling $9.2 million. Net income from continuing operations for Calavo was reported at $4.7 million, or $0.26 per diluted share, when compared to $5.4 million, or $0.30 per diluted share, in the same quarter last year. Adjusted net income was noted at $10.2 million, or $0.57 per diluted share, showing slight growth from the last year's figures.
Insights from Year-To-Date Performance
In examining the nine-month period ending July 31, 2025, Calavo achieved total net sales of $523.8 million, which represents a commendable 7% increase compared to the same period last year. Noteworthy observations during this period include:
Year-To-Date Insights
- Fresh segment sales totaled $470.3 million, marking a solid 6% growth.
- Prepared segment sales also demonstrated growth, reaching $53.5 million, which is a 10% increase from the previous year.
Gross profit for the nine-month period stood at $52.0 million, up 1% from the previous year, showcasing resilience. However, SG&A expenses were down by 19%, reflecting improved operational efficiency and reduced overheads.
Net Income Performance
For this period, net income attributable to Calavo Growers, Inc. surged to $16.1 million or $0.89 per diluted share, compared to $9.3 million or $0.52 per diluted share reported last year. Adjusted net income increased to $23.8 million or $1.33 per diluted share versus $19.2 million or $1.08 per diluted share in the previous year.
Strategic Commentary from Management
Lee Cole, the President and CEO of Calavo Growers, provided insight into the company's performance, acknowledging the impact of regulatory challenges but emphasizing the strength and growth potential within the prepared segment. The company has been able to meet the rising demand with strong volume increases. The resolution of the FDA issue was seen as a significant turning point that allows Calavo to proceed with expanded sales initiatives.
In closing, Calavo's robust balance sheet demonstrated stability, with cash and cash equivalents reported at $63.8 million, leading to a total liquidity position of $114.3 million, without any outstanding borrowings.
Looking Forward
Calavo Growers is optimistic about the upcoming quarter and is set to leverage its continued commitment to innovation and quality service delivery. Investors and stakeholders are encouraged to keep an eye on the expected growth trajectory of the prepared product segment which could significantly contribute to the company's future performance.
Frequently Asked Questions
1. What were the total net sales reported by Calavo Growers in the third quarter?
The total net sales were reported at $178.8 million for the third quarter.
2. How did the prepared segment perform in terms of sales growth?
The prepared segment experienced a remarkable 40% increase in sales compared to the prior year.
3. What were the main challenges faced by Calavo Growers?
Challenges included a temporary FDA detention hold that impacted avocado imports, leading to unusual costs.
4. What is Calavo Growers’ outlook for the future?
The company remains optimistic, particularly for its prepared segment, anticipating significant growth.
5. What is the adjusted net income for the nine-month period?
Adjusted net income for the nine-month period was $23.8 million or $1.33 per diluted share.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.